CLINICAL_TRIALS
trial_result
· 2024-01-12
Clinical Trial Update: Study Evaluating Betrixaban in Pediatric Participants [Phase 1]
Summary
Phase 1 pediatric trial evaluating betrixaban for venous thromboembolism prophylaxis has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: VTE Prophylaxis | Phase 1 | Status: TERMINATED | Results posted: 2024-01-12